Pharma sales rep salary survey finds annual incomes rising, but COVID-19 concerns mounting
An annual survey of pharma sales rep salaries showed another year-over-year increase, but it also revealed concerns about the impact of the COVID-19 pandemic. Salaries averaged more than $150,000 in 2019, for an increase of 6%. However, three-fourths of the pharma...
Biogen cracks down on travel after 3 execs test positive for coronavirus
The novel coronavirus has hit home at Biogen, where three executives who traveled to a headquarters management meeting have tested positive for the illness. At last week’s meeting, a “number of attendees reported varying degrees of flu-like symptoms,” the...
Why FDA can’t disclose the first coronavirus-related drug shortage
Around 10 PM ET last night, the FDA said that it is aware of a drug shortage related to an active pharmaceutical ingredient (API) manufacturer affected by the coronavirus, but the agency stopped short of revealing what drug it is. “The shortage is due to an issue with...
The top 10 ad spenders in Big Pharma for 2019
Direct-to-consumer drug ads tend to strike a dissonant chord. However, fan and foe can count on one thing: Prescription DTC advertising is here to stay. The evidence? Surviving more than 20 years of numerous legal, regulatory and perception challenges on its way to...
States reject drug wholesalers’ $18B opioid settlement offer: WSJ
After years of opioid litigation and a multibillion-dollar settlement offer from the nation’s top drug distributors, nearly two dozen U.S. states have rejected their proposal, The Wall Street Journal reports. Twenty-one state attorneys general sent a letter to...LATEST NEWS
More anti-epidemic measures eased today
Bulgaria resumes the “green corridor” walk-in vaccination scheme
30,000 Bulgarians receive jabs against Covid-19 in last three days
CureVac’s mRNA coronavirus shot boasts one advantage over Pfizer and Moderna counterparts—refrigerated storage
COVID-19 vaccine players will split $100B in sales and $40B in profits, with Moderna leading the way: analyst